Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penghui Niu

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The Oncologist|April 27, 2023
Perioperative Chemotherapy Could Not Improve the Prognosis of Gastric Cancer Patients With Mismatch Repair Deficiency: A Multicenter, Real-World StudyLulu Zhao, Yongliang Fu, Penghui Niu, et al.
Journal of Translational Medicine|December 6, 2022
Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencingYingtai Chen, Jianhua Yin, Lulu Zhao, et al.
Theranostics|June 6, 2022
Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancerYumin Li, Xueda Hu, Ruichai Lin, et al.
International Journal of Surgery (London, England)|April 10, 2023
Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational studyXianchun Gao, Lulu Zhao, Nannan Zhang, et al.
Cancer Letters|January 25, 2026
Changing Landscape in Stage, Treatment and Survival of Gastric Cancer in China 1998-2022: Insights of 40,158 patients from the National Gastric Cancer CohortLulu Zhao, Zhihao Chen, Fan Zhang, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The Oncologist|April 27, 2023
Perioperative Chemotherapy Could Not Improve the Prognosis of Gastric Cancer Patients With Mismatch Repair Deficiency: A Multicenter, Real-World StudyLulu Zhao, Yongliang Fu, Penghui Niu, et al.
Journal of Translational Medicine|December 6, 2022
Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencingYingtai Chen, Jianhua Yin, Lulu Zhao, et al.
Theranostics|June 6, 2022
Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancerYumin Li, Xueda Hu, Ruichai Lin, et al.
International Journal of Surgery (London, England)|April 10, 2023
Impact of HER2 on prognosis and benefit from adjuvant chemotherapy in stage II/III gastric cancer patients: a multicenter observational studyXianchun Gao, Lulu Zhao, Nannan Zhang, et al.
Cancer Letters|January 25, 2026
Changing Landscape in Stage, Treatment and Survival of Gastric Cancer in China 1998-2022: Insights of 40,158 patients from the National Gastric Cancer CohortLulu Zhao, Zhihao Chen, Fan Zhang, et al.
Pageof 4